| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 23,130 | $30 | $786.3K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 95,000 | $1 | $380K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 35,780 | $10 | $357.8K |
| J3262 | Injection, tocilizumab, 1 mg | 33,960 | $10 | $169.8K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 9,030 | $10 | $72.2K |
| J0897 | Injection, denosumab, 1 mg | 3,660 | $20 | $69.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 560 | $50 | $25.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 250 | $80 | $21.3K |
| 76881 | In this procedure, the provider uses ultrasound to examine the complete joint for any defect or abnormality. The image appears in real time on a monitor, and a permanent image with interpretation is… | 270 | $40 | $9.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 150 | $60 | $8.4K |